Literature DB >> 22028207

Coping with time scales in disease systems analysis: application to bone remodeling.

Stephan Schmidt1, Teun M Post, Lambertus A Peletier, Massoud A Boroujerdi, Meindert Danhof.   

Abstract

In this study we demonstrate the added value of mathematical model reduction for characterizing complex dynamic systems using bone remodeling as an example. We show that for the given parameter values, the mechanistic RANK-RANKL-OPG pathway model proposed by Lemaire et al. (J Theor Biol 229:293-309, 2004) can be reduced to a simpler model, which can describe the dynamics of the full Lemaire model to very good approximation. The response of both models to changes in the underlying physiology and therapeutic interventions was evaluated in four physiologically meaningful scenarios: (i) estrogen deficiency/estrogen replacement therapy, (ii) Vitamin D deficiency, (iii) ageing, and (iv) chronic glucocorticoid treatment and its cessation. It was found that on the time scale of disease progression and therapeutic intervention, the models showed negligible differences in their dynamic properties and were both suitable for characterizing the impact of estrogen deficiency and estrogen replacement therapy, Vitamin D deficiency, ageing, and chronic glucocorticoid treatment and its cessation on bone forming (osteoblasts) and bone resorbing (osteoclasts) cells. It was also demonstrated how the simpler model could help in elucidating qualitative properties of the observed dynamics, such as the absence of overshoot and rebound, and the different dynamics of onset and washout.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22028207      PMCID: PMC3230316          DOI: 10.1007/s10928-011-9224-2

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  39 in total

1.  Reproductive aging, menopause, and health outcomes.

Authors:  JoAnn V Pinkerton; Dale W Stovall
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

2.  Impact of protein binding on receptor occupancy: a two-compartment model.

Authors:  Lambertus A Peletier; Neil Benson; Piet H van der Graaf
Journal:  J Theor Biol       Date:  2010-06-02       Impact factor: 2.691

3.  Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling.

Authors:  Svetlana V Komarova; Robert J Smith; S Jeffrey Dixon; Stephen M Sims; Lindi M Wahl
Journal:  Bone       Date:  2003-08       Impact factor: 4.398

4.  Impact of plasma-protein binding on receptor occupancy: an analytical description.

Authors:  Lambertus A Peletier; Neil Benson; Piet H van der Graaf
Journal:  J Theor Biol       Date:  2008-10-02       Impact factor: 2.691

5.  On the validity of the steady state assumption of enzyme kinetics.

Authors:  L A Segel
Journal:  Bull Math Biol       Date:  1988       Impact factor: 1.758

Review 6.  Growth factors and bone formation in osteoporosis: roles for IGF-I and TGF-beta.

Authors:  P Marie
Journal:  Rev Rhum Engl Ed       Date:  1997-01

7.  Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.

Authors:  Susan L Greenspan; Ronald D Emkey; Henry G Bone; Stuart R Weiss; Norman H Bell; Robert W Downs; Clark McKeever; Sam S Miller; Michael Davidson; Michael A Bolognese; Anthony L Mulloy; Norman Heyden; Mei Wu; Amarjot Kaur; Antonio Lombardi
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

8.  Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study.

Authors:  R F Laan; P L van Riel; L B van de Putte; L J van Erning; M A van't Hof; J A Lemmens
Journal:  Ann Intern Med       Date:  1993-11-15       Impact factor: 25.391

Review 9.  The direct role of vitamin D on bone homeostasis.

Authors:  René St-Arnaud
Journal:  Arch Biochem Biophys       Date:  2008-04-06       Impact factor: 4.013

Review 10.  Vitamin D in health and disease: current perspectives.

Authors:  Ran Zhang; Declan P Naughton
Journal:  Nutr J       Date:  2010-12-08       Impact factor: 3.271

View more
  16 in total

1.  A semi-mechanistic model of bone mineral density and bone turnover based on a circular model of bone remodeling.

Authors:  Erno van Schaick; Jenny Zheng; Juan Jose Perez Ruixo; Ronald Gieschke; Philippe Jacqmin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-06-30       Impact factor: 2.745

Review 2.  Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.

Authors:  Jane P F Bai; Justin C Earp; Venkateswaran C Pillai
Journal:  AAPS J       Date:  2019-06-03       Impact factor: 4.009

3.  QSP Toolbox: Computational Implementation of Integrated Workflow Components for Deploying Multi-Scale Mechanistic Models.

Authors:  Yougan Cheng; Craig J Thalhauser; Shepard Smithline; Jyotsna Pagidala; Marko Miladinov; Heather E Vezina; Manish Gupta; Tarek A Leil; Brian J Schmidt
Journal:  AAPS J       Date:  2017-05-24       Impact factor: 4.009

Review 4.  Merging systems biology with pharmacodynamics.

Authors:  Ravi Iyengar; Shan Zhao; Seung-Wook Chung; Donald E Mager; James M Gallo
Journal:  Sci Transl Med       Date:  2012-03-21       Impact factor: 17.956

Review 5.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

6.  Application of a mechanism-based disease systems model for osteoporosis to clinical data.

Authors:  Teun M Post; Stephan Schmidt; Lambertus A Peletier; Rik de Greef; Thomas Kerbusch; Meindert Danhof
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-01-12       Impact factor: 2.745

Review 7.  Pharmacology of bisphosphonates.

Authors:  Serge Cremers; Matthew T Drake; F Hal Ebetino; John P Bilezikian; R Graham G Russell
Journal:  Br J Clin Pharmacol       Date:  2019-02-28       Impact factor: 4.335

8.  Integrated pharmacometrics and systems pharmacology model-based analyses to guide GnRH receptor modulator development for management of endometriosis.

Authors:  M M Riggs; M Bennetts; P H van der Graaf; S W Martin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-10-17

9.  Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models.

Authors:  Meindert Danhof
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-30       Impact factor: 2.745

10.  Application of a Systems Pharmacology-Based Placebo Population Model to Analyze Long-Term Data of Postmenopausal Osteoporosis.

Authors:  J Berkhout; J A Stone; K M Verhamme; B H Stricker; M C Sturkenboom; M Danhof; T M Post
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.